Global Clopidogrel Bisulfate Tablets Market Size To Worth USD 1.86 Billion By 2033 | CAGR Of 4.39%
Category: HealthcareGlobal Clopidogrel Bisulfate Tablets Market Size To Worth USD 1.86 Billion By 2033
According to a research report published by Spherical Insights & Consulting, The Global Clopidogrel Bisulfate Tablets Market Size is expected to Grow from USD 1.21 Billion in 2023 to USD 1.86 Billion by 2033, at a CAGR of 4.39% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 213 pages with 100 Market data tables and figures & charts from the report on the “Global Clopidogrel Bisulfate Tablets Market Size, Share, and COVID-19 Impact Analysis, By Dose (75mg, 300mg, and Others), By Indications (Stroke, Cardiovascular Diseases, Peripheral Artery Disease, and Others), By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospital Pharmacies, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.” Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/clopidogrel-bisulfate-tablets-market
The clopidogrel bisulfate tablet market focuses on the development, production, and commercialization of clopidogrel bisulfate tablets as a platelet inhibitor for treating myocardial infarction and strokes in patients with cardiovascular diseases or blood circulation disorders. The market growth is driven by the increasing prevalence of cardiovascular diseases, which are the leading cause of death globally. The World Health Organization states that cardiovascular diseases account for 32% of all global deaths, with 85% of these deaths due to heart attacks and strokes. Preventing these diseases involves addressing risk factors like tobacco use, unhealthy diet, inactivity, alcohol use, and air pollution. The increasing number of elderly individuals is fueling the demand for drugs like clopidogrel bisulfate tablets, which is expected to rise consistently due to the growing incidence of cardiovascular diseases and an emphasis on preventive healthcare. The growing geriatric population escalates the demand for cardiac treatment, leading to the expansion of the market for clopidogrel bisulfate tablets. However, adverse effects associated with this tablet may restrict the growth of the market.
The 75mg segment held a substantial share in 2023 and is predicted to grow at a significant CAGR during the predicted period.
Based on the dose, the global clopidogrel bisulfate tablets market is categorized as 75mg, 300mg, and others. Among these, the 75mg segment held a substantial share in 2023 and is predicted to grow at a significant CAGR during the predicted period. This is ascribed to its efficacy, compatibility with adult and geriatric populations, blood clot prevention, and peripheral artery disease complications minimization.
The cardiovascular diseases segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the indications, the global clopidogrel bisulfate tablets market is categorized as stroke, cardiovascular diseases, peripheral artery disease, and others. Among these, the cardiovascular diseases segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. The segment's growth is driven by rising cardiovascular disease prevalence, clopidogrel use, sedentary lifestyles, unhealthy eating, lack of physical activity, and geriatric population.
The hospital pharmacies segment held a substantial share in 2023 and is predicted to grow at a remarkable CAGR throughout the projected timeframe.
Based on the distribution channel, the global clopidogrel bisulfate tablets market is categorized into retail pharmacies, online pharmacies, hospital pharmacies, and others. Among these, the hospital pharmacies segment held a substantial share in 2023 and is predicted to grow at a remarkable CAGR throughout the projected timeframe. This is driven by bulk availability of clopidogrel bisulfate tablets, cost-effectiveness, drug facility compounding and dispensing, specialized services, and quality medications with dosage regimens.
North America is expected to hold the greatest share of the global clopidogrel bisulfate tablets market over the forecast period.
Get more details on this report -
North America is expected to hold the greatest share of the global clopidogrel bisulfate tablets market over the forecast period. North America's established healthcare system, high cardiovascular disease incidence, and substantial healthcare spending drive its market growth. Major pharmaceutical companies and favorable reimbursement policies facilitate this growth. The availability of generic versions has increased accessibility and affordability, leading to increased clopidogrel adoption. Advanced healthcare systems and strict regulations ensure safety and effectiveness in the North American market.
Asia Pacific is predicted to grow at the fastest CAGR throughout the estimated period. The Asia Pacific region's economic growth is driving increased healthcare investments and awareness of cardiovascular diseases, leading to a demand for advanced medical treatments. China and India are key market drivers due to their large populations and improved healthcare systems. Pharmaceutical companies can expand their presence and capitalize on the growing patient population. The clopidogrel bisulfate market is also expanding due to increased awareness of preventive care and generic formulations.
Major key players in the global clopidogrel bisulfate tablets market are Torrent Pharmaceuticals Ltd., Sandoz International GmbH, Aurobindo Pharma Limited, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Sanofi S.A., Novartis AG, Cipla Inc., Glenmark Pharmaceuticals Ltd., Lupin Limited, Apotex Inc., Dr. Reddy Laboratories Ltd., and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In June 2023, Ascendia Pharmaceuticals developed a novel nanoemulsion IV formulation for clopidogrel using EmulSol nanotechnology, which has received Investigational New Drug (IND) approval from the FDA. The collaboration between Ascendia and AcuteBio aims to improve treatment methods for coronary artery disease (CAD), particularly for stent placements.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global clopidogrel bisulfate tablets market based on the below-mentioned segments:
Global Clopidogrel Bisulfate Tablets Market, By Dose
- 75mg
- 300mg
- Others
Global Clopidogrel Bisulfate Tablets Market, By Indications
- Stroke
- Cardiovascular Diseases
- Peripheral Artery Disease
- Others
Global Clopidogrel Bisulfate Tablets Market, By Distribution Channel
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
- Others
Global Clopidogrel Bisulfate Tablets Market, By Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?